Introduction
Fragile X syndrome is an X-linked semi-dominantly inherited disorder with reduced penetrance and does not follow a classical Mendelian pattern of inheritance.
It represents the most frequent form of inherited severe cognitive deficit. [1] Males as well as females can be affected, although the latter to a lesser extent. In addition, both males and females can be unaffected carriers.
Among the western populations the frequency of fragile X syndrome is estimated to be 1/4000 births and 1/8000 female births. [2] Few studies in Indian population show the frequency of Fragile X (A) syndrome among idiopathic mentally retarded (MR) males as approximately 7%. [3] [4] [5] Fragile X syndrome is caused by mutation of the FMR 1 gene on the X chromosome. This site is present at Xq27.3 and the gene spans 39 Kb containing 17 exons.
Mutation is located in the untranslated region of the first exon and is characterized by the presence of an array comprising a repeat sequence of the trinucleotide CGG interspersed with single AGG repeats along its length.
The array is polymorphic with respect to the number of CGG repeats it includes as well as the position of the interspersed AGGs. [6, 7] The different alleles are usually referred to by the "repeat number" of CGG in the array and this repeat number is the principal determinant of whether an allele is regarded as normal or mutant.
Normal subjects have 2 to 50 copies of the repeat and individuals with fragile X syndrome typically have more than 200 of these repeats, a condition known as a full mutation (FM). The FM prevents transcription of the FMR-1 gene, resulting in absence of the protein product.
In normal transmitting males and female carriers the repeats range from 50 to 199 copies and this intermediate number is known as a premutation (PM). [6] The number of repeats in a PM is potentially unstable and may expand into the FM range. However, this has been observed to take place only during female meiosis.
This means that no daughter of a male with a PM would ever be affected but they would be at risk of having a child with FM.
A more distal fragile site, FRAXE located at Xq 28 has been associated with amplification of a GCC repeat which is 600 Kb distal to FRAXA. Normal subjects have 6 to 25 copies of this repeat, whereas subjects with more than 200 copies of the GCC repeat express the FRAXE site. [8, 9] Direct analysis of the CGG expansion mutation by Southern blotting has almost replaced the cytogenetic analysis for the laboratory diagnosis of the fragile X syndrome. However, blotting is a relatively expensive and labour intensive procedure, particularly in the context of screening routine referrals for fragile X syndrome, the great majority of whom will be negative. In this study we screened 294 idiopathic mentally retarded patients using PCR method to detect both FRAXA and FRAXE mutations simultaneously and a PCR based assay to detect methylation of the CpG island upstream of the FMR-1 gene in patients with an expanded FRAXA allele.
Materials and Methods
From the year 1998 to 2002, 294 cases having mental retardation (MR) were referred to Genetics Clinic, AIIMS.
After excluding other possible causes all these patients were screened for fragile X syndrome. For each patient a pedigree was drawn and a detailed family history was taken. All patients were examined in detail and a clinical scoring for Fragile X syndrome was done. [10, 11] The family was counseled about the genetic testing and an informed consent was taken. 10 ml of blood was collected in EDTA and DNA was extracted using standard phenol-chloroform extraction protocol. [12] The following molecular genetic studies were done: of genomic DNA, 2 µl of 10x restriction endonuclease buffer and 100 µl/ml BSA, in a total volume of 20 µl (made up with distilled water) were used. A total of 12 µl of the methylation sensitive enzymes BssHII or EagI were added to one of the tubes while the other contained no enzyme. The tubes were then incubated at 50ºC (BssHII) or at 37ºC (EagI) overnight. A PCR was then set-up for each of the 2 tubes using the protocol previously described. [13] A EDTA buffer for improved resolution of differences of one repeat unit. The gel was silver stained for better specificity using the standard protocol [14] [ Figure 3 ].
(iv) Southern Blotting
Southern blotting was done for all PCR positive cases and for initial ten PCR negative cases. For FRAXA mutation using double digestion of genomic DNA with Eco RI and EagI and Southern blots were hybridized with probe pp2 [5] . Southern blotting was carried out in Dr. B.K.
Thelma's lab, South Campus, Delhi University, New Delhi.
For Southern blotting random priming technique was used for labeling the probe (pP2) using [a-32p] dCTP. Probe elution was carried out using sephadex G-50 column and after each wash, the column was monitored for radioactivity along the whole tube [ Figure 4 ].
Results
Out of the 294 cases, 271 were males and 10 females with idiopathic MR. The rest of 13 females were the relatives of the patient (sister(s), mother, mother's sister) who were at high risk of having a PM. Majority of the cases were from North India, few were from other states Figure 5 shows a pedigree with a positive family history. The age range of the subjects was 2-22 years (mean age 7.9+ S.D. = 3.98).
All the 294 cases were screened for both FRAXA and FRAXE mutations by PCR approach. About 92% of routine referrals for Fragile X testing were for male patients and only 8% were females. We found a total of 36 (12.24%) cases showing FRAXA mutation (FM or widely again has a long laboratory turn round time, is relatively expensive and has got hazards associated with the use of radioisotopes. So PCR method is a rapid and cheap method for initial screening. The best protocol would be to perform PCRs for initial screening followed by Southern blots for confirmation.
Based on an earlier Indian study using Cytogenetic techniques the prevalence of fragile X (A) syndrome has been reported as 1.8% in patients of both sexes with MR, 2.8% among male patients with idiopathic MR and 5.8% among subjects with non specific MR using defined clinical criteria. [15] In another study, the frequency of Fragile X (A) syndrome among the idiopathic MR male patients was 6.38% based on Cytogenetic method and 5.27% using molecular studies. [3] Yet another Indian study gives a rate of 7% positivity among unclassified MR cases based on molecular analysis. [4] In 1986, a population study of school children in the city of Coventry gave an overall prevalence of 1/952 in males and females for fragile X syndrome. [16] Later on many of these children diagnosed as having fragile X syndrome based on cytogenetic method were found negative on molecular studies. So in 1997 a revised prevalence figure of 1/2720 males was calculated based on molecular investigations. [17] Another study was conducted in Japanese population in 1994 comparing the Cytogenetic and molecular analysis for fragile X and the results were similar. [18] In our study we screened idiopathic male MR cases without using any clinical scoring system for inclusion, with a positivity rate of 7.48% which is comparable to previous studies. The results of this study and previous studies re-emphasize the need to evaluate all idiopathic mentally retarded males for fragile X syndrome. It was also evident from our data that clinical scores were not invariably high in Frax positive cases.
Although neither male nor female with a PM has been shown to have reduced IQ, subtle emotional and neurocognitive effects may be present. [19] In half of the females with FM fragile X phenotype have obvious learning disabilities and in about 20% neurocognitive deficits have been observed. [20] The milder phenotype in females and the variable expression are due to random X chromosome inactivation. The physical features seen in fragile X syndrome are neither specific nor constant. The features also change with time, becoming more apparent as the patient gets older.
Western studies have reported a positivity rate between 10.5-14.6% when clinical screening criteria are used. If no selection criteria are used and all patients with idiopathic MR are tested for fragile X, the reported detection rate ranges from 0.6% to 14%. [11, [21] [22] [23] The present study gives a total detection rate including both the sexes of 12.24% which is in concurrence with the earlier studies. Considering the significance of positive diagnosis specially with regard to genetic counseling and clinical outcome, screening of all idiopathic MR males should be acceptable. We conclude that PCR based screening for fragile X is reliable and should be used as an initial screening test for all idiopathic mentally retarded males.
